Transform drug development and discovery
At Element Biosciences, we believe the future of therapeutic discovery will be driven by a multiomic approach—seamlessly integrating genomics, transcriptomics, proteomics, and morphology to reveal a comprehensive view of biology. Our AVITI24™ system is designed to support pharma research teams with high-resolution molecular data that accelerates innovation, informs smarter decisions, and drives research to support better patient outcomes.
With streamlined workflows, unmatched data quality, and cost-effective scalability, Element enables pharma to go beyond sequencing and into 5 dimensional multiomic discovery.
Why pharma leaders partner with Element Biosciences
Multiomic by designAVITI24 is engineered for seamless co-detection of multiple data types—with paired RNA, protein, and cellular morphology measurements at single cell, spatial resolution. In just one run, you can capture the full molecular picture across disease states, time courses, compound dosages, and patient cohorts. |
Direct-from-sample insightsWith a streamlined workflow, AVITI24 delivers automated, onboard multiomic detection directly in your cells—including in sample sequencing of up to 100 bp (at launch, may extend). With no library preparation and minimal off-instrument sample handling, it accelerates your path to actionable insights. |
Deep biological profilingFrom mechanism-of-action studies to therapeutic response profiling, our technology empowers you to interrogate complex biology with precision—advancing target discovery, biomarker development, functional genomics, and patient stratification efforts. |
Flexible and open ecosystemYou're not locked into proprietary tools. Our AVITI platforms work with your preferred NGS prep kits, analysis pipelines, and informatics platforms. Rapid customization workflows give you the freedom to tailor solutions to your pipeline and research model. |
Cost-effective scalabilityMultiomic research at scale is finally within reach. With just a single AVITI24 system, you can generate rich, reproducible datasets across larger cohorts without budgetary trade-offs. |
Applications of high-dimensional multiomics in pharma R&D
 | Target discovery & validationIntegrate transcriptomic, protein expression, and morphological data to identify functional drug targets with greater specificity and confidence. |
 | CRISPR screening for functional genomicsAutomate CRISPR screening workflows with speed and scale to identify new targets and build functional genomics maps. |
 | Biomarker identificationDiscover molecular signatures that predict therapeutic response, disease progression, or adverse events. |
 | Mechanism of action (MoA) elucidationDe-risk early discovery by linking perturbations to phenotype and understand how drug candidates interact with and regulate biological systems through rich, layered molecular data. |
 | Companion diagnostics research developmentGenerate robust multiomic evidence to support research in co-development of diagnostics and targeted therapies. |
Intelligent multiomics for pharma
The AVITI24 reimagines the traditional sequencer as an intelligent multiomics system, empowering you to capture subcellular spatial architecture, molecular profiles, longitudinal dynamics, and molecular interactions — all from a single sample. It's the next step in precision medicine, helping pharma teams uncover what single-omic data alone can’t reveal.
Empowering innovation across the R&D spectrum
Element Biosciences collaborates with pharmaceutical teams to develop scalable, research-focused solutions tailored to today’s most complex drug discovery and development challenges. From early discovery to translational research, our technology enables you to ask better questions and make faster, data-driven decisions to advance therapeutic pipelines with confidence.
 |